Working with biopharma to unleash the power of RWE

Solutions designed to reduce risk, increase value, and accelerate the delivery of safe and effective treatments

Empowering decision makers in biopharma at every phase of the lifecycle, from clinical development to post-market assessment.

  • Research & Development

    Optimize clinical development, prove safety and effectiveness

  • HEOR & Market Access

    Demonstrate asset value

  • Enterprise-wide

    Streamline evidence across assets and portfolios

“We believe that strategic partnerships will advance our capabilities for rapid analytics. The Aetion Evidence Platform has helped reduce the completion time for UCB’s RWE initiatives by 50% and has enhanced our capabilities to run multiple concurrent studies.”

— Dr. Eddie Lee
Head, US HEOR Strategy, UCB

“Aetion is a leader in turning real-world data into RWE to inform critical decision-making across product development, reimbursement, and commercialization. Our partnership will accelerate our late-stage clinical programs and bring our therapy to the millions of patients living with MCI and Alzheimer’s disease, where safer options are still needed.“

— Brent Vaughan, CEO
Cognito Therapeutics